MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Computer Programs and Systems Retained Earnings 2011-2026 | CPSI
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Computer Programs and Systems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.13 M | 53.9 M | 38.1 M | 19.6 M | 9.72 M | -5.02 M | -19 M | 10 M | 31.2 M | 41.8 M | 34.4 M | 24.3 M | 25.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 53.9 M | -19 M | 21 M |
Quarterly Retained Earnings Computer Programs and Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.31 M | -11.9 M | -14.5 M | -9.9 M | -755 K | 3.63 M | 50.6 M | 54.2 M | 57 M | 53.9 M | 51.4 M | 49.2 M | 46.2 M | 38.1 M | 32.7 M | 29.9 M | 23.8 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 9.72 M | 9.72 M | -2.78 M | 9.72 M | -5.02 M | -5.02 M | -5.02 M | -14.5 M | -19 M | -19 M | -19 M | -19 M | 10 M | 10 M | 10 M | 10 M | 31.2 M | 31.2 M | 31.2 M | 31.2 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 34.4 M | 34.4 M | 34.4 M | 34.4 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | 25.8 M | 25.8 M | 25.8 M | 25.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 57 M | -19 M | 19.6 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B |  USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
-606 M | $ 4.18 | 0.84 % | $ 392 M | USA |
 |
Health Catalyst
HCAT
|
-1.19 B | $ 2.46 | -1.8 % | $ 148 M | USA |
 |
HealthStream
HSTM
|
109 M | $ 22.42 | -1.45 % | $ 681 M | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
206 M | $ 98.07 | 0.31 % | $ 8.39 B | USA |
 |
American Well Corporation
AMWL
|
-1.97 B | $ 5.23 | 0.77 % | $ 78.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
-66.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
-926 M | $ 2.61 | 1.76 % | $ 207 M |  China |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.78 | -2.63 % | $ 1.07 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 13.25 | -4.33 % | $ 227 M | USA |
 |
Omnicell
OMCL
|
383 M | $ 50.47 | 6.35 % | $ 2.32 B | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
Progyny
PGNY
|
144 M | $ 27.54 | 2.76 % | $ 2.36 B | USA |
 |
Phreesia
PHR
|
-743 M | $ 16.91 | -3.54 % | $ 923 M | USA |
 |
Premier
PINC
|
-485 M | $ 28.26 | - | $ 2.33 B | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 0.53 | 1.56 % | $ 2.76 M | China |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
Schrödinger
SDGR
|
-526 M | $ 18.67 | -0.52 % | $ 1.36 B | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 19.32 | -3.35 % | $ 2.26 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-16.2 B | $ 7.57 | - | $ 1.29 B | USA |
 |
Veeva Systems
VEEV
|
2.74 B | $ 242.72 | 1.46 % | $ 39 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.2 | -1.51 % | $ 292 K | USA |